Article published In: Argumentation and Patient Centered Care
Edited by Francisca Snoeck Henkemans, Roosmaryn Pilgram and Nanon Labrie
[Journal of Argumentation in Context 7:2] 2018
► pp. 209–227
Implicit persuasion in medical decision-making
An overview of implicitly steering behaviors and a reflection on explanations for the use of implicitly steering behaviors
Published online: 12 October 2018
https://doi.org/10.1075/jaic.18032.eng
https://doi.org/10.1075/jaic.18032.eng
Abstract
If the arguments to support a recommendation are partly implicit, the free exchange of ideas between discussants
can be hampered. In this paper, we will focus on the potential pitfall for clinicians when informing patients about treatment
options: implicit persuasion. We will describe a set of implicitly persuasive behaviors observed
during decision-making consultations, and reflect on how these behaviors could undermine efforts to stimulate patient
participation in decision-making. We will also reflect on possible explanations for why clinicians exhibit such behaviors.
Article outline
- 1.Information provision is a key component of the decision-making process
- 1.1Implicit persuasion: Definition and its prevalence in clinical practice
- 1.2Is implicit persuasion inherently wrong?
- 2.Implicitly persuasive behaviors
- 2.1Clinical context
- 2.2Category 1: Unbalanced presentation of benefits and side-effects
- 2.2.1Minimal number of side-effects presented
- 2.2.2Emphasizing the benefits or downplaying the side-effects of treatment
- 2.2.3Minimizing the treatment’s impact
- 2.2.4Emphasizing the ability to control the side-effects of the treatment
- 2.2.5Presenting the side-effects after the final treatment decision has been made
- 2.3Category 2: Presenting treatment recommendations as authorized decisions
- 2.3.1Presenting treatment as an authorized decision
- 2.4Category 3: Creating the illusion of decision control
- 2.4.1From mild to serious treatment – a gradual decision
- 2.4.2Having one treatment implicitly tag along with another
- 2.4.3The illusory power to decide
- 2.5Category 4: Persuading patients using (clinical) experience
- 2.5.1Making assertions about the patients' personality
- 2.5.2Deterring vs. encouraging: using others as examples
- 2.5.3Giving the impression that undergoing or foregoing treatment is quite unusual
- 3.Reflection on potential explanations for the use of implicit persuasion
- 3.1Attempts to prevent information overload
- 3.2Lack of awareness of the gap in knowledge between doctors and patients
- 3.3Lack of awareness of own preferences
- 3.4Overcorrecting patients’ perception of treatment burden
- 3.5Overestimation of patient’s assertiveness
- 4.Conclusions
References Key publications
References (25)
Couët, Nicholas, Sophie Desroches, Hubert Robitaille, Hugues Vaillancourt, Annie Leblanc, Stéphane Turcotte, Glyn Elwyn and France Légaré. 2015. “Assessments of the extent to which health-care providers involve patients in decision making: A systematic review of studies using the OPTION instrument”. Health Expectation 181:542–561.
Davies, Christina, Hongchao Pan, Jon Godwin, Richard Gray, Rodrigo Arriagada, Vinod Raina, Mirta Abraham, Victor H. Medeiros Alencar, Atef Badran, Xavier Bonfill, Joan Bradbury, Michael Clarke, Rory Collins, Susan R. Davis, Antonella Delmestri, John F. Forbes, Peiman Haddad, Ming-Feng Hou, Moshe Inbar, Hussein Khaled, Joanna Kielanowska, Wing-Hong Kwan, Beela S. Mathew, Indraneel Mittra, Bettina Muller, Antonio Nicolucci, Octavio Peralta, Fany Pernas, Lubos Petruzelka, Tadeusz Pienkowski, Ramachandran Radhika, Balakrishnan Rajan, Maryna T. Rubach, Sera Tort, Gerard Urrutia, Miriam Valentini, Yaochen Wang, Richard Peto and the Adjuvant Tamoxifen: Longer Against Shorter Collaborative Group. 2013. “Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial”. Lancet 3811:805–816.
Early Breast Cancer Trialists Collaborative Group. 1998. “Polychemotherapy for early breast cancer: an overview of the randomised trials”. Lancet. 3521:930–942. [URL]
Engelhardt, Ellen G., Hanneke C. de Haes, Cornelis J. van de Velde, Ellen M. Smets, Arwen H. Pieterse and Anne M. Stiggelbout. 2015. “Oncologists’ weighing of the benefits and side effects of adjuvant systemic therapy: Has it changed over time?” Acta Oncologica 541:956–959. [URL]
Engelhardt, Ellen G., Arwen H. Pieterse, Anja van der Hout, Hanneke J. de Haes, Judith R. Kroep, Patricia Quarles van Ufford-Mannesse, Johanneke E. Portielje, Ellen M. Smets and Anne M. Stiggelbout. 2016. “Use of implicit persuasion in decision making about adjuvant cancer treatment: A potential barrier to shared decision making”. European Journal of Cancer 661:55–66.
Fowler, Jr. Floyd J., Mary M. Collins, Peter C. Albertsen, Anthony Zietman, Diana B. Elliott and Michael J. Barry. 2000. “Comparison of Recommendations by Urologists and Radiation Oncologists for Treatment of Clinically Localized Prostate Cancer”. JAMA. 2831:3217.
Hahlweg Pola, Jana, Hoffmann, Martin Harter, Dominick L. Frosch, Glyn Elwyn and Isabelle Scholl. 2015. “In Absentia: An Exploratory Study of How Patients Are Considered in Multidisciplinary Cancer Team Meetings”. PLoSOne.; 101:e0139921. [URL]
Henry, Stephen G., Danielle Czarnecki, Valerie C. Kahn, Wen-Ying Chou, Angela Fagerlin, Peter A. Ubel, David R. Rovner, Stewart C. Alexander, Sara J. Knight and Margaret Holmes-Rovner. 2015. “Patient-physician communication about early stage prostate cancer: analysis of overall visit structure”. Health Expectations 181:1757–68.
Henselmans Inge, Hanneke W., Van Laarhoven, Jane Van der Vloodt, Hanneke C. De Haes and Ellen M. Smets. 2017. Shared decision making about palliative chemotherapy: A qualitative observation of talk about patients’ preferences. Palliative Medicine 311:625–633.
Herk-Sukel, Myrthe P. van, Lonneke V. van de Poll-Franse, Adri C. Voogd, Grard A. Nieuwenhuijzen, Jan Willem Coebergh and Ron M. Herings. 2010. “Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis”. Breast Cancer Research and Treatment 1221:843–851.
Hershman, Dawn L., Lawrence H. Kushi, Theresa Shao, Donna Buono, Aaron Kershenbaum, Wei-Yann Tsai, Louis Fehrenbacher, Scarlett L. Gomez, Sunita Miles and Alfred I. Neugut. 2010. “Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients”. Journal of Clinical Oncology 281:4120–4128.
Holmes-Rovner, Margaret, Jeffrey S. Montgomery, David R. Rovner, Laura D. Scherer, Jesse Whitfield, Valerie C. Kahn, Edgar C. Merkle, Peter A. Ubel and Angela Fagerlin. 2015. “Informed Decision Making: Assessment of the Quality of Physician Communication about Prostate Cancer Diagnosis and Treatment”. Medical Decision Making 351:999–1009.
Karnieli-Miller, Orit and Zvi Eisikovits. 2009. “Physician as partner or salesman? Shared decision making in real-time encounters”. Social Science & Medicine 691:1–8.
Kunneman, Marleen, Corrie A. Marijnen, Monique C. Baas-Thijssen, Yvette M. van der Linden, Tom Rozema, Karin Muller, Elisabeth D. Geijsen, Anne M. Stiggelbout, Arwen H. Pieterse. 2015. “Considering patient values and treatment preferences enhances patient involvement in rectal cancer treatment decision making”. Radiotherapy and Oncology 1171:338–342.
Kunneman, Marleen, Corrie A. M. Marijnen, Tom Rozema, Heleen M. Ceha, Diana A. R. H. Grootenboers, Karin J. Neelis, Anne M. Stiggelbout and Arwen H. Pieterse. 2015. “Decision consultations on preoperative radiotherapy for rectal cancer: large variation in benefits and harms that are addressed”. British Journal of Cancer 1121:39–43.
Molewijk, Albert, Anne M. Stiggelbout, Wilma Otten, Heleen M. Dupuis and Job Kievit. 2008. “First the facts, then the values? Implicit normativity in evidence-based decision aids for shared decision-making”. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 1021:415–420.
Pieterse, Arwen H., Inge Henselmans, Hanneke C. de Haes, Caro C. Koning, Elisabeth D. Geijsen and Ellen M. Smets. 2011. “Shared decision making: prostate cancer patients’ appraisal of treatment alternatives and oncologists’ eliciting and responding behavior, an explorative study”. Patient Education and Counseling 851:e251–e259.
Saadatmand, Sepideh, Reini Bretveld, Sabine Siesling and Madeleine M. Tilanus-Linthorst. 2015. “Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173,797 patients”. British Medical Journal 3511:h4901.
Scherr, Karen A., Angela Fagerlin, Timothy Hofer, Laura D. Scherer, Margaret Holmes-Rovner, Lillie D. Williamson, Valerie C. Kahn, Jeffrey S. Montgomery, Kirsten L. Greene, Biqi Zhang and Peter A. Ubel. 2017. “Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment Decisions”. Medical Decision Making 371:56–69.
Stiggelbout, Anne M., Arwen H. Pieterse and Hanneke C. De Haes. 2015. “Shared decision making: Concepts, evidence, and practice”. Patient Education and Counseling 981:1172–1179.
Tversky, Amos and Daniel Kahneman. 1973. “Availability: A heuristic for judging frequency and probability”. Cognitive Psychology 51:207–232.
Wouters, Hans, Anne M. Stiggelbout, Marcel L. Bouvy, Gemma A. Maatman, Erica C. Van Geffen, Robbert Vree, Johan W. Nortier, Liset van Dijk. 2014. “Endocrine therapy for breast cancer: assessing an array of women’s treatment experiences and perceptions, their perceived self-efficacy and nonadherence”. Clinical Breast Cancer 141:460–467.
Engelhardt, EG, A. H. Pieterse, A. van der Hout, H. J. de Haes, J. R. Kroep, P. Quarles van Ufford-Mannesse, J. E. Portielje, E. M. Smets and A. M. Stiggelbout. 2016. “Use of implicit persuasion in decision making about adjuvant cancer treatment: A potential barrier to shared
decision making”. European Journal of Cancer 661:55–66.
Cited by (6)
Cited by six other publications
Engelhardt, E.G., R.S.J.M. Schmitz, M.A. Gerritsma, C.M.T. Sondermeijer, E. Verschuur, J.H.E. Houtzager, R. Griffioen, N. Bijker, R.M. Mann, V. Retèl, F.H. van Duijnhoven, J. Wesseling, E.M.A. Bleiker, Alastair Thompson, Serena Nik-Zainal, Elinor J. Sawyer, Helen Davies, Andrew Futreal, Nicholas Navin, E. Shelley Hwang, Jos Jonkers, Jacco van Rheenen, Fariba Behbod, Esther H. Lips, Marjanka Schmidt, Lodewyk F.A. Wessels, Daniel Rea, Proteeti Bhattacharjee, Hilary Stobart, Deborah Collyar, Donna Pinto, Marja van Oirsouw, S. Alaeikhanehshir & L. Elshof
Akkermans, Aranka, Sanne Prins, Amber S. Spijkers, Jean Wagemans, Nanon H. M. Labrie, Dick L. Willems, Marcus J. Schultz, Thomas G. V. Cherpanath, Job B. M. van Woensel, Marc van Heerde, Anton H. van Kaam, Moniek van de Loo, Anne Stiggelbout, Ellen M. A. Smets & Mirjam A. de Vos
de Veer, Mathijs R., Merel Hermus, Charlène J. van der Zijden, Berend J. van der Wilk, Bas P.L. Wijnhoven, Anne M. Stiggelbout, Jan Willem T. Dekker, Peter Paul L.O. Coene, Jan J. Busschbach, Jan J.B. van Lanschot, Sjoerd M. Lagarde & Leonieke W. Kranenburg
Geurts, Esther M.A., Carina A.C.M. Pittens, Gudule Boland, Sandra van Dulmen & Janneke Noordman
van Someren, Jamie L., Vicky Lehmann, Jacqueline M. Stouthard, Anne M. Stiggelbout, Ellen M. A. Smets & Marij A. Hillen
This list is based on CrossRef data as of 12 november 2025. Please note that it may not be complete. Sources presented here have been supplied by the respective publishers. Any errors therein should be reported to them.
